Messenger RNA (mRNA) vaccines are one of the biggest medical breakthroughs of recent years. It was first introduced during ...
Zacks Investment Research on MSN
MRNA stock on the move: What sparked the 33.5% jump in the past week?
Shares of Moderna MRNA have surged 33.5% over the past week, adding nearly $8 billion to the company's market value. The ...
A new study, led by researchers at Children's Hospital of Philadelphia (CHOP), identified tiny pieces of messenger RNA that are missing in pediatric high-grade glioma tumors but not in normal brain ...
A tiny chemical modification commonly found on messenger RNAs plays a surprisingly large role in how cells respond to stress, according to a study led by Weill Cornell Medicine investigators. The ...
A pizza shop with 30 delivery people ought to be able to deliver a lot of pizzas—if their cars don't break down on the way. Likewise, genes that produce a lot of messenger RNA (mRNA) molecules can ...
A spiral strand of messenger RNA, colored orange. Raina Biosciences has unveiled a new artificial intelligence–based platform for designing messenger RNA. Credit: Shutterstock A new artificial ...
Vaccines have been in the news lately, and not because of their lifesaving potential. Some US parents have grown hesitant about vaccinating their children. And the vaccine skepticism expressed by ...
Asianet Newsable on MSN
mRNA stock rallies over 40% in June: Moderna bets its future on cancer, autoimmune disease and AI-powered mRNA
Cancer was a key focus, with programs targeting solid tumors, Lynch syndrome, melanoma, and non-small cell lung cancer.
Vaccines using mRNA technology weren’t immune to the latest round of federal research cuts. Health and Human Services Secretary Robert F. Kennedy Jr. said this week that he’s pulling the plug on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results